SEC Form 4 · accession 0001179110-18-013562
Teladoc Health, Inc. · TDOC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Hirschhorn
Officer — Executive VP, COO and CFO
Period of report
Nov 7, 2018
Accepted (ET)
Dec 7, 2018 · 4:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001477449
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 7, 2018 | M | 1,001 | $1.67 | A | 3,285 | D | |
| Common Stock | Nov 7, 2018 | M | 3,081 | $12.21 | A | 6,366 | D | |
| Common Stock | Nov 7, 2018 | M | 4,000 | $22.30 | A | 10,366 | D | |
| Common Stock | Nov 20, 2018 | M | 683 | $6.01 | A | 11,049 | D | |
| Common Stock | Nov 20, 2018 | M | 834 | $18.98 | A | 11,883 | D | |
| Common Stock | Nov 20, 2018 | M | 774 | $22.30 | A | 12,657 | D | |
| Common StockF1 | Dec 4, 2018 | S | 10,000 | $64.96 | D | 2,657 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F2 | $1.67 | Nov 7, 2018 | M | 1,001 | D | — | Dec 11, 2023 | Common Stock | 1,001 | 8,009 | D |
| Employee Stock Option (right to buy)F3 | $12.21 | Nov 7, 2018 | M | 3,081 | D | — | Mar 7, 2026 | Common Stock | 3,081 | 86,275 | D |
| Employee Stock Option (right to buy)F4 | $22.30 | Nov 7, 2018 | M | 4,000 | D | — | Mar 3, 2027 | Common Stock | 4,000 | 103,419 | D |
| Employee Stock Option (right to buy)F5 | $6.01 | Nov 20, 2018 | M | 683 | D | — | Sep 10, 2024 | Common Stock | 683 | 6,835 | D |
| Employee Stock Option (right to buy)F6 | $18.98 | Nov 20, 2018 | M | 834 | D | — | Sep 16, 2026 | Common Stock | 834 | 28,333 | D |
| Employee Stock Option (right to buy)F4 | $22.30 | Nov 20, 2018 | M | 774 | D | — | Mar 3, 2027 | Common Stock | 774 | 102,645 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on June 15, 2018.
- F2The option vests as to 25% of the shares on December 11, 2014. The remainder of the shares vest in 36 equal monthly installments thereafter.
- F3The option vests as to 25% of the shares on March 7, 2017. The remainder of the shares vest in 36 equal monthly installments thereafter.
- F4The option vests as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter.
- F5The option vests as to 25% of the shares on September 10, 2015. The remainder of the shares vest in 36 equal monthly installments thereafter.
- F6The option vests as to 25% of the shares on September 16, 2017. The remainder of the shares vest in 36 equal monthly installments thereafter.